abstract |
Disclosed are pyrazine derivatives, pharmaceutical compositions containing them, and methods of using them to treat a disorder or condition the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as an anxiety-related disorder or affective disorder. |